We are a young and dynamic company in Australia with a focus on innovation and an expanding product portfolio servicing a diversity of stakeholders, partners and customers in the healthcare sector. A proven track record of success under continuously evolving market dynamics demonstrates our determination and ability to achieve results.
Established in Australia in 2001 as Altana Pharma and becoming Nycomed a Takeda company in October 2011, we have always recognised the pioneering spirit is not a concept limited to the early phases of an organisation’s life, but a business approach in itself. It requires a continuous commitment to maintain a responsive, reliable, flexible, diverse and results-focused organisation.
As one of Australia’s top 30 pharmaceutical companies, our focus extends to three core groups of healthcare providers which will drive our future growth in a dynamic market place.
In the primary care and hospital settings, our products Somac® (pantoprazole) and Mezavant (mesalazine) for the treatment of gastrointestinal diseases, Penthrox® (methoxyflurane) for acute pain relief and Alvesco® (ciclesonide) for the treatment of chronic asthma have earned a trusted position in the minds of patients and prescribers. In the self-medication arena, Nycomed has introduced Somac HR for heartburn relief, Travelan to reduce the risk of travellers' diarrhoea and a range of calcium and vitamin D supplements under the Calcia brand name.
To continue building our business, our organisation must defend our current value, expand and diversify.
About Takeda - Who we are
As the largest pharmaceutical company in Japan and a leader in the global industry, Takeda’s mission is to strive toward better health for patients worldwide through leading innovation in medicine. It has a commercial presence covering more than 70 countries, with particular strength in Asia, North America, Europe and fast-growing emerging markets including Latin America, Russia-CIS and China.
What we do
With a broad portfolio of products and a powerful pipeline, we work in a wide range of therapeutic areas, particularly gastroenterology, respiratory and tissue management.
Where we work
Takeda has a commercial presence covering more than 70 countries, with particular strength in Asia, North America, Europe and fast-growing emerging markets including Latin America, Russia-CIS and China.